Lightning Round: I like Rubrik, I don’t think the stock should have dropped, says Jim CramerSeptember 17, 2025
Workday CEO Carl Eschenbach: There’s a narrative that AI is eating into software, that is falseSeptember 17, 2025
Share Facebook Twitter LinkedIn Pinterest Email Johnson & Johnson executive vice president and CFO Joseph Wolk discusses high drug prices and breaks down the company’s growth outlook.
